Literature DB >> 28846760

The Role of Environmental Factors in the Pathogenesis of Inflammatory Bowel Diseases: A Review.

Dror S Shouval1,2,3, Paul A Rufo3,4.   

Abstract

Importance: Inflammatory bowel diseases (IBD), such as Crohn disease and ulcerative colitis, are chronic relapsing conditions that affect a growing number of children worldwide. The pathogenesis of these disorders is complex and thought to be mediated by the interplay between genetic susceptibility, microbial dysbiosis, and environmental factors that result in a dysregulated immune system. This dysregulation ultimately mediates intestinal inflammation and clinical symptoms typically observed in patients with IBD including abdominal pain, diarrhea, and poor growth. A dramatic increase in the incidence of IBD has been observed in the past 2 decades, mainly in developed countries but also in developing regions. This increased incidence has paralleled changes in diet, sanitation conditions, and lifestyle habits. Observations: The increased incidence of IBD can likely be attributed to more than evolving genetic diversity alone and strongly suggests that environmental factors are playing an increasingly critical role in the development of these disorders and in the modulation of IBD clinical phenotypes over time. Here, we review the data suggesting how different environmental factors may modulate the risk of developing IBD including diets, smoking, lifestyle choices, enteric infections, appendectomy, air pollution, and the use of medications, with an emphasis on antibiotics. We will also discuss how early-life events can influence the subsequent likelihood of developing one of these diseases and suggest directions that can help decrease the risk of IBD in particularly high-risk populations. Conclusions and Relevance: Dramatic lifestyle changes in the last century have substantially improved the quality of life but are also associated with increased risk of various diseases. Pediatricians should be aware of the changing epidemiology of IBD and environmental factors that modulate the risk of developing these conditions.

Entities:  

Mesh:

Year:  2017        PMID: 28846760     DOI: 10.1001/jamapediatrics.2017.2571

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  31 in total

1.  Probiotics for induction of remission in Crohn's disease.

Authors:  Berkeley N Limketkai; Anthony K Akobeng; Morris Gordon; Akinlolu Adedayo Adepoju
Journal:  Cochrane Database Syst Rev       Date:  2020-07-17

2.  Aggravated gut inflammation in mice lacking the taste signaling protein α-gustducin.

Authors:  Pu Feng; Jinghua Chai; Huilan Yi; Kevin Redding; Robert F Margolskee; Liquan Huang; Hong Wang
Journal:  Brain Behav Immun       Date:  2018-04-17       Impact factor: 7.217

Review 3.  Mechanisms of Disease: Inflammatory Bowel Diseases.

Authors:  Guilherme Piovezani Ramos; Konstantinos A Papadakis
Journal:  Mayo Clin Proc       Date:  2019-01       Impact factor: 7.616

4.  Blastocystis and Clostridioides difficile: Evidence for a Synergistic Role in Colonization Among IBD Patients with Emphasis on Ulcerative Colitis.

Authors:  Masoumeh Azimirad; Sara Mohammad Ali Gol; Ehsan Javanmard; Hamed Mirjalali; Abbas Yadegar; Hamid Asadzadeh Aghdaei; Shabnam Shahrokh; Hedieh Balaii; Amir Sadeghi; Mohammad Reza Zali
Journal:  Turk J Gastroenterol       Date:  2021-06       Impact factor: 1.852

Review 5.  Ambient Air Pollution and Pediatric Inflammatory Bowel Diseases: An Updated Scoping Review.

Authors:  Ricardo G Suarez; Alvaro R Osornio-Vargas; Eytan Wine
Journal:  Dig Dis Sci       Date:  2022-06-25       Impact factor: 3.487

6.  Lizhong decoction ameliorates ulcerative colitis in mice via modulating gut microbiota and its metabolites.

Authors:  Junfeng Zou; Yumeng Shen; Mengjun Chen; Zhimiao Zhang; Suwei Xiao; Chen Liu; Yue Wan; Lei Yang; Shu Jiang; Erxin Shang; Dawei Qian; Jinao Duan
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-17       Impact factor: 4.813

Review 7.  Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis.

Authors:  Junfeng Zou; Chen Liu; Shu Jiang; Dawei Qian; Jinao Duan
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

Review 8.  Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions.

Authors:  John Gubatan; Steven Levitte; Akshar Patel; Tatiana Balabanis; Mike T Wei; Sidhartha R Sinha
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

9.  Ketogenesis alleviates TNFα-induced apoptosis and inflammatory responses in intestinal cells.

Authors:  Ji Tae Kim; Dana L Napier; Jinhwan Kim; Chang Li; Eun Y Lee; Heidi L Weiss; Qingding Wang; B Mark Evers
Journal:  Free Radic Biol Med       Date:  2021-06-01       Impact factor: 8.101

10.  Neu3 neuraminidase induction triggers intestinal inflammation and colitis in a model of recurrent human food-poisoning.

Authors:  Won Ho Yang; Julia S Westman; Douglas M Heithoff; Markus Sperandio; Jin Won Cho; Michael J Mahan; Jamey D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.